Sustained Delivery of a HIF-1 Antagonist for Ocular Neovascularization
NIH Public Access
Author Manuscript
J Control Release . Author manuscript; available in PMC 2014 December 28.
N
Published in final edited form as:
I
H
J Control Release . 2013 December 28; 172(3): . doi:10.1016/j.jconrel.2013.10.008.
-
P
A
A
u Sustained Delivery of a HIF-1 Antagonist for Ocular
t
h
o Neovascularization
r
M
a 1,2,* 1,3,4,* 1,2 1,2
您可能关注的文档
- Silicic volcanism on Mars evidenced by tridymite in high-SiO2 sedimentary rock at Gale crater.PDF
- Silencing Mediated by the Schizosaccharomyces pombe HIRA Complex Is Dependent upon the Hpc2-Like Protein, Hip4.PDF
- SILAC-based proteomic quantification of chemoattractant-induced cytoskeleton dynamics on a second to minute timescale.PDF
- Silk Fibroin Conduits A Cellular and Functional Assessment of Peripheral Nerve Repair.PDF
- Simian immunodeficiency virus infection in rhesus macaques induces selective tissue specific B cell defects in double positive CD21+CD27+ memory B cells.PDF
- Similar Colds in Allergic Asthma Subjects and Non-Atopic Subjects After Inoculation with Rhinovirus-16.PDF
- Silica Nanowires Templated by Amyloid-like Fibrils.PDF
- Silencing of Neuroligin Function by Postsynaptic Neurexins.PDF
- SIgA Binding to Mucosal Surfaces Is Mediated by Mucin-Mucin Interactions.PDF
- Similar effects of feature-based attention on motion perception and pursuit eye movements at different levels of awareness.PDF
原创力文档

文档评论(0)